Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
复发/难治性边缘区淋巴瘤患者接受伊布替尼治疗的预测因素和疗效:一项多中心队列研究
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-022-01316-1
Epperla, Narendranath; Zhao, Qiuhong; Chowdhury, Sayan Mullick; Shea, Lauren; Moyo, Tamara K; Reddy, Nishitha; Sheets, Julia; Weiner, David M; Geethakumari, Praveen Ramakrishnan; Kandarpa, Malathi; Bruno, Ximena Jordan; Thomas, Colin; Churnetski, Michael C; Hsu, Andrew; Zurbriggen, Luke; Tan, Cherie; Lindsey, Kathryn; Maakaron, Joseph; Caimi, Paolo F; Torka, Pallawi; Bello, Celeste; Ayyappan, Sabarish; Karmali, Reem; Kim, Seo-Hyun; Kress, Anna; Kothari, Shalin; Sawalha, Yazeed; Christian, Beth; David, Kevin A; Greenwell, Irl Brian; Janakiram, Murali; Kenkre, Vaishalee P; Olszewski, Adam J; Cohen, Jonathon B; Palmisiano, Neil; Umyarova, Elvira; Wilcox, Ryan A; Awan, Farrukh T; Alderuccio, Juan Pablo; Barta, Stefan K; Grover, Natalie S; Ghosh, Nilanjan; Bartlett, Nancy L; Herrera, Alex F; Shouse, Geoffrey